Scientists and patient advocates have largely overlapping agendas, but, ultimately, their agendas diverge, said Fran Visco, president of the National Breast Cancer Coalition, the organization that ushered in a new era in the politics of cancer research and delivery of care.
An analysis by researchers from the International Agency for Research on Cancer casts doubt on validity of an endpoint used in key studies of multi-cancer detection tests.
